Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study.

Eigenbrodt AK, Laigaard PP, Hassani M, Othman MH, Amiri M, Møller K, Kjaergaard J, Kondziella D

Open source

DOI
10.1136/bmjopen-2026-124508
Published
2026 Sep 22
Container
BMJ open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2026-124508,
  title = {Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study.},
  author = {Eigenbrodt AK and Laigaard PP and Hassani M and Othman MH and Amiri M and Møller K and Kjaergaard J and Kondziella D},
  year = {2026},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2026-124508},
  url = {https://doi.org/10.1136/bmjopen-2026-124508}
}

RIS

TY  - JOUR
TI  - Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study.
AU  - Eigenbrodt AK
AU  - Laigaard PP
AU  - Hassani M
AU  - Othman MH
AU  - Amiri M
AU  - Møller K
AU  - Kjaergaard J
AU  - Kondziella D
PY  - 2026
JO  - BMJ open
DO  - 10.1136/bmjopen-2026-124508
UR  - https://doi.org/10.1136/bmjopen-2026-124508
ER  - 

APA

AK, E., PP, L., M, H., MH, O., M, A., K, M., J, K., & D, K. (2026). Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study.. BMJ open. https://doi.org/10.1136/bmjopen-2026-124508

Source records